Metacare Co., Ltd. (118000) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Metacare Co., Ltd. (118000:KRX), powered by AI.

Current Price
₩1,490
P/E Ratio
51.4
Market Cap
25.6B
Sector
Healthcare
What is the Metacare Co., Ltd. stock price forecast?

Metacare Co., Ltd. is currently trading at ₩1,490. View real-time AI analysis on Alpha Lenz.

What is Metacare Co., Ltd. insider trading activity?

View the latest insider trading data for Metacare Co., Ltd. on Alpha Lenz.

What is Metacare Co., Ltd.'s P/E ratio?

Metacare Co., Ltd.'s P/E ratio is 51.4.

Metacare Co., Ltd.

KRX · 118000
₩1,490+29(+1.98%)Market closedKRX regular session 09:00–15:30 KST
Ask about Metacare Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Metacare Co., Ltd. trades at a P/E of 51.4 (premium valuation) with modest ROE of 0.4%. 3Y revenue CAGR of 19.8% highlights clear growth momentum.

Ask for details

Company Overview

Metacare Co., Ltd. is a key player in the healthcare sector, primarily focused on providing a wide array of healthcare solutions. The company's core operations include the development, manufacturing, and distribution of medical equipment and supplies, catering to both domestic and international markets. Metacare Co., Ltd. is dedicated to enhancing the quality of patient care through innovative technologies and products, enabling healthcare providers to deliver efficient and effective treatments. Their product portfolio is extensive, encompassing diagnostic tools, surgical devices, and patient monitoring systems. Through continual research and development initiatives, Metacare Co., Ltd. strives to stay at the forefront of medical innovation, addressing evolving healthcare needs and challenges. The company plays a critical role in the healthcare ecosystem, supporting hospitals, clinics, and medical professionals by supplying essential tools that promote better health outcomes. With its commitment to reliability and quality, Metacare Co., Ltd. is a significant entity within the medical technology industry, contributing to advancements in patient care and healthcare delivery on a global scale.

CEO이수진
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31

Company Statistics

FY 2025

Profile

₩25,594,826,640Market Cap
₩32,822,071,200Revenue
17.18MShares Out
31Employees

Margins

30.48%Gross
21.29%EBITDA
4.04%Operating
-0.62%Pre-Tax
-0.65%Net

Valuation

51.37P/E
0.21P/B
0.78EV/Sales
12.15EV/EBITDA
-5.20P/FCF

Growth (CAGR)

19.78%Rev 3Yr
37.74%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.12%ROA
0.42%ROE
1.26%ROIC

Financial Health

₩1,594,297,450Cash & Cash Equivalents
₩75,389,539,970Net Debt
63.63%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Metacare Co., Ltd. (ticker: 118000) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - General). It has approximately 31 employees. Market cap is $25.6B.

The current price is ₩1,490 with a P/E ratio of 51.37x and P/B of 0.21x.

ROE is 0.42% and operating margin is 4.04%. Annual revenue is $32.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Metacare Co., Ltd. (118000) Stock Forecast 2026 ₩1,490 — Price, Financials & Analyst Targets | Alpha Lenz